piquindone

Known as: 2,6-dimethyl-3-ethyl-4,4a,5,6,7,8,8a,9-octahydro-4a,8a-1H-pyrrolo(2,3g)isoquinolin-4-one, 3-ethyl-2,6-dimethyl-4,4a,5,6,7,8,8a,9-octahydro-4a,8a-1H-pyrrolo(2,3g)isoquinolin-4-one 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2001
02419842001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
A range of 3- and 6-substituted 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 with D-1 agonist activity were compared for… (More)
Is this relevant?
1989
1989
The new, extremely potent and enantioselective D-2 agonist LY 163502 failed to induce compulsive stereotyped behaviour. Very low… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
1989
1989
Molecular graphic design coupled with PCILO and crystallographic results have been used to investigate the three-dimensional… (More)
Is this relevant?
1987
1987
The structure of the potent dopamine-D2 antagonist, raclopride, (S)-3,5-dichloro-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6… (More)
Is this relevant?
1987
1987
Piquindone (RO22-1319), a new "atypical" neuroleptic, was administered for 2 weeks to 37 schizophrenic patients, and the effects… (More)
Is this relevant?
1986
1986
We have hypothesized that symptoms of Tourette Syndrome (TS) may represent D2 (dopamine-2) receptor hyperactivity. We treated 4… (More)
Is this relevant?
1986
1986
This report describes a rapid, sensitive and selective method for the determination of piquindone in canine plasma and piquindone… (More)
Is this relevant?
1986
1986
The ability of dopamine agonists and antagonists to compete with [3H]spiperone binding to rat striatal membrane preparations at 4… (More)
Is this relevant?
1984
1984
Ro 22-1319, a novel pyrroloisoquinoline compound, is a potent antipsychotic agent with low potential for extrapyramidal effects… (More)
Is this relevant?